Human fibrinogen (Tonrol Bio-Pharmaceutical)

人纤维蛋白原（同路生物）

Report date: 2026/01/30 17:13:56

Base Information

Drug NameHuman fibrinogen (Tonrol Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsDisseminated Intravascular CoagulationAfibrinogenemiaBlood Coagulation Disorders +[4] 
Global Approved IndicationsAfibrinogenemia
Approved Indications in ChinaAfibrinogenemia
Original Approved Country/TerritoryMainland China
Original Approved Date2026/01/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonrol Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTonrol Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDisseminated Intravascular CoagulationAfibrinogenemiaBlood Coagulation Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A